Average Co-Inventor Count = 7.27
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Chemocentryx, Inc. (106 from 215 patents)
2. Millennium Pharmaceuticals Limited (14 from 850 patents)
3. Amgen Inc. (3 from 1,975 patents)
4. Other (1 from 832,880 patents)
5. Cor Therapeutics, Inc. (1 from 92 patents)
125 patents:
1. 12497383 - Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases
2. 12448373 - Azetidinyl-acetamides as CXCR7 inhibitors
3. 12371433 - Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases
4. 12268675 - Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors
5. 12139475 - 2-oxindole compounds
6. 12054484 - Substituted tetrahydropyrans as CCR2 modulators
7. 12018016 - Aryl sulfonyl (hydroxy) piperidines as CCR6 inhibitors
8. 12012403 - Aryl sulfonyl compounds as CCR6 inhibitors
9. 12011439 - Combination therapy using C—C chemokine receptor 4 (CCR4) antagonists and one or more immune checkpoint inhibitors
10. 11945805 - Inhibitors of CXCR2
11. 11883391 - Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-IL-23 blocking antibodies
12. 11872217 - Indanes as PD-L1 inhibitors
13. 11866429 - Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases
14. 11845729 - Processes and intermediates in the preparation of C5aR antagonists
15. 11834452 - CXCR7 antagonists